These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10169617)

  • 1. Model compliance plan for clinical laboratories.
    Lavanty D
    Clin Lab Sci; 1997; 10(4):178-9. PubMed ID: 10169617
    [No Abstract]   [Full Text] [Related]  

  • 2. The reasonable and necessary criterion and Medicare contractor review of claims: efforts to combat fraud, waste and abuse in the Medicare program.
    Nicholson G; Robins L
    Spec Law Dig Health Care Law; 2000 Feb; (251):9-18. PubMed ID: 10747458
    [No Abstract]   [Full Text] [Related]  

  • 3. OIG issues model compliance plan for clinical laboratories.
    Becker S
    Benders Health Care Law Mon; 1997 Apr; ():3-5. PubMed ID: 10168184
    [No Abstract]   [Full Text] [Related]  

  • 4. A brief history of medical diagnosis and the birth of the clinical laboratory. Part 4--Fraud and abuse, managed-care, and lab consolidation.
    Berger D
    MLO Med Lab Obs; 1999 Dec; 31(12):38-42. PubMed ID: 11184281
    [No Abstract]   [Full Text] [Related]  

  • 5. What you need to know about the 2004 OIG work plan.
    Siegel S
    Health Care Law Mon; 2003 Dec; ():3-12. PubMed ID: 14712524
    [No Abstract]   [Full Text] [Related]  

  • 6. Devices at heart of civil fraud suit.
    Scott L
    Mod Healthc; 1996 Jan; 26(4):21. PubMed ID: 10154131
    [No Abstract]   [Full Text] [Related]  

  • 7. Publication of OIG compliance program guidance for clinical laboratories--HHS. Notice.
    Fed Regist; 1998 Aug; 63(163):45076-87. PubMed ID: 10182693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discussion of pharmaceutical industry practices viewed as illegal by the federal government.
    Nino K
    Health Care Law Mon; 1999 Nov; ():8-16. PubMed ID: 11067433
    [No Abstract]   [Full Text] [Related]  

  • 9. Solicitation of new safe harbors and special fraud alerts--OIG, HHS. Notice of intent to develop regulations.
    Fed Regist; 1998 Dec; 63(237):68223-4. PubMed ID: 10338886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical care program compliance--a year 2000 recipient perspective of Medicare claims.
    Eddy CA; Liberman A; Falen T
    Health Care Manag (Frederick); 2000 Dec; 19(2):22-37. PubMed ID: 11146872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex rules in place to combat fraud and abuse. Part I: Understanding the basics.
    Brown CA
    Bull Am Coll Surg; 2000 Aug; 85(8):15-8, 32. PubMed ID: 11349553
    [No Abstract]   [Full Text] [Related]  

  • 12. Compliance plan can head off problems with Medicare fraud and abuse laws.
    Public Sect Contract Rep; 1998 Aug; 4(8):122-5. PubMed ID: 10182908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal by Fresenius Medical Care to fold in separately billable laboratory tests.
    Rosenthal AF; Mahlke KF
    Nephrol News Issues; 1999 Dec; 13(12):11. PubMed ID: 11984926
    [No Abstract]   [Full Text] [Related]  

  • 14. Looking for trouble. State, federal investigators seek tips on problem HMOs.
    Hallam K; Rauber C
    Mod Healthc; 1998 Aug; 28(32):14. PubMed ID: 10183058
    [No Abstract]   [Full Text] [Related]  

  • 15. Tips for challenging an audit based on statistical sampling.
    Shaw PW; Tichner JB
    J Health Law; 1999; 32(4):649-56. PubMed ID: 10662443
    [No Abstract]   [Full Text] [Related]  

  • 16. National Medicare fraud alert issued.
    Pa Med; 1993 Jul; 96(7):43. PubMed ID: 8414605
    [No Abstract]   [Full Text] [Related]  

  • 17. Fraud and abuse--could this be you?
    Tucker RP
    J Med Assoc Ga; 1993 Mar; 82(3):113-4. PubMed ID: 8459179
    [No Abstract]   [Full Text] [Related]  

  • 18. A summary of fraud and abuse issues affecting clinical research programs.
    Roberts CM
    QRC Advis; 1998 Oct; 14(12):9-12. PubMed ID: 10185022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinton wants Medicare anti-fraud effort expanded; labs focus on legislative priorities.
    Szabo J
    MLO Med Lab Obs; 2000 Mar; 32(3):14. PubMed ID: 10947449
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare Program; statistical standards for evaluating intermediary performance during fiscal year 1981--Health Care Financing Administration. General notice with comment period.
    Fed Regist; 1981 Jul; 46(135):36749-53. PubMed ID: 10298219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.